Top Markets
#1 Black Phoenix Black Phoenix +21,376.82%
#2 Nesa Nesa +742.64%
#3 ADO Protocol ADO Protocol +103.82%
#4 Cortex Cortex +95.56%
#5 Ontology Gas Ontology Gas +85.65%
#6 Kinesis Silver Kinesis Silver +53.16%
#7 Magma Finance Magma Finance +30.19%
#8 OpenEden OpenEden +29.92%
#9 PondCoin PondCoin +27.37%
#10 Pons Pons +24.66%
Coin of the day
Black Phoenix Black Phoenix
設定
言語
日本
通貨
USD
テーマ
Axcella Health Inc. Axcella Health Inc.

Axcella Health Inc.

AXLA
株式のランク #18693
Axcella Health Inc. is a U.S.-based clinical-stage biotechnology firm focused... Axcella Health Inc. is a U.S.-based clinical-stage biotechnology firm focused on developing novel therapeutic compositions derived from endogenous metabolic modulators. These aim to address complex diseases and improve overall health. The company's primary drug candidates are AXA1665 and AXA1125. AXA1665 is currently undergoing Phase 2 clinical trials, where it is being evaluated for its potential to lower the risk of recurrent overt hepatic encephalopathy. Meanwhile, AXA1125 is progressing through multiple trials: a Phase 2b study targeting non-alcoholic steatohepatitis (NASH) treatment, and a Phase 2a study exploring its efficacy as a therapy for Long COVID patients. Founded in 2008, the entity initially operated as Newco LS16, Inc. before officially adopting the name Axcella Health Inc. in June 2016. Its operations are headquartered in Cambridge, Massachusetts.
株価
$4.58
最終同期: 2025-02-06
時価総額
$189.73M
変化（1日）
0.00%
変化（1年）
0.00%
国
US
取引 Axcella Health Inc. (AXLA)

カテゴリー

Healthcare
Axcella Health Inc.（AXLA）の収益
Aug 2026 時点の収益 TTM: 0
Axcella Health Inc. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Axcella Health Inc. の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH